Announcements Trials
Browse Landscape

Phase

Phase 2 202Phase 1/2 33Phase 3 32Phase 1 31Phase NA 12Phase 2/3 5Phase EARLY_PHASE1 2Phase 4 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Epstein-Barr Virus Infections 1

Interventions

Magnetic Resonance Spectroscopy 59Cyclophosphamide 44pembrolizumab 34Radiotherapy 30fludarabine 27Nivolumab 26Biopsy 26Metformin 22Fluorodeoxyglucose F18 22Specimen Handling 20Bevacizumab 20Temozolomide 17Radiosurgery 17Cisplatin 16Carboplatin 14Fluorouracil 13Dexamethasone 13Paclitaxel 12Gemcitabine 12Etoposide 12gallium 68 PSMA-11 11durvalumab 11X-Rays 11Surgical Procedures, Operative 11Radiation 11Positron Emission Tomography Computed Tomography 11Letrozole 11Irinotecan 11Ipilimumab 11Surveys and Questionnaires 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER × toripalimab × Clear all
NCT06577532 2025-05-21

Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors

Ruijin Hospital

Phase EARLY_PHASE1 Recruiting
56 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04690036 2021-06-29

PD-1 Antibody for Reactive EBV After BMT

Beijing Friendship Hospital

Phase EARLY_PHASE1 Unknown
20 enrolled

Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡